Eli Lilly has finalized a deal to acquire Houston-based startup CrossBridge Bio, marking its latest investment in the rapidly evolving... Read more
Tag: #M&A
Obsidian Therapeutics to go public via $350 million merger with Galera
Obsidian Therapeutics and Galera Therapeutics have entered into a definitive all-stock merger agreement, supported by $350 million in concurrent private... Read more
Sun Pharma readies $12B binding offer for Organon
Indian pharmaceutical giant Sun Pharmaceutical is reportedly finalizing a binding offer to acquire Organon, a women's health-focused Merck & Co.... Read more
CapVest completes majority acquisition of global pharma leader STADA
CapVest Partners LLP has officially announced the completion of its acquisition of a majority stake in STADA Arzneimittel AG, a... Read more
Gilead Sciences acquires biotech firm Tubulis in a deal worth up to $5 billion
Gilead Sciences has announced an agreement to acquire Tubulis, a German biotechnology startup, in a transaction valued at potentially $5... Read more
Neurocrine Biosciences executes historic $2.9B acquisition of Soleno Therapeutics
Defying its long-standing reputation as a potential takeover target, Neurocrine Biosciences has taken a decisive step by acquiring Soleno Therapeutics... Read more
Samsung Biologics acquires GSK manufacturing facility in Maryland
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has completed the acquisition of GSK’s manufacturing site in Rockville,... Read more
Eli Lilly enters $7.8 billion agreement to acquire Centessa Pharmaceuticals for sleep-wake treatments
Eli Lilly has agreed to acquire Centessa Pharmaceuticals for up to $47 per share, valuing the transaction at approximately $7.8... Read more
Biogen secures $5.6B acquisition of Apellis to bolster immunology and renal portfolio
In a strategic move to accelerate near-term revenue growth, Biogen has announced a definitive agreement to acquire Apellis Pharmaceuticals for... Read more








